August 30, 2016 12:37 PM ET

Pharmaceuticals

Company Overview of Chugai Pharmaceutical Co. Ltd.

Executive Profile

Hisashi Hara

Outside Audit & Supervisory Board Member, Chugai Pharmaceutical Co. Ltd.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
69--

Background

Mr. Hisashi Hara serves as the Chairman of Nagashima Ohno & Tsunematsu. Mr. Hara has been a Director of Everglory Group Limited since March 2014. His principal practice areas include a variety of transnational and domestic transactions with emphasis on real estate acquisition, development, financing and securitization, M&A, joint ventures and corporate restructuring. He became a partner in 1983. In 1991, he became managing partner of Nagashima & Ohno, and in 2000, managing ...

Corporate Headquarters

Nihonbashi Mitsui Tower
Tokyo, -- 103-8324

Japan

Phone: 81 3 3281 6611
Fax: 81 3 3281 6607

Board Members Memberships

Chairman
2014-Present
Director

Education

LLB 1972
Tokyo University of Science
Master's Degree 1980
Harvard Law School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$1.3M
Miles D. White Chairman of The Board, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Erez Vigodman Chief Executive Officer, President, Director and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
$3.7M
Stefan Oschmann Chairman of Executive Board, Chief Executive Officer and Chairman of Corporate Responsibility Committee
Merck KGaA
$5.4M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Chugai Pharmaceutical Co. Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.